Cytochrome P-450 CYP3A Inhibitors
"Cytochrome P-450 CYP3A Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 CYP3A.
Descriptor ID |
D065692
|
MeSH Number(s) |
D27.505.389.500.503 D27.505.519.389.335.503
|
Concept/Terms |
Cytochrome P-450 CYP3A Inhibitors- Cytochrome P-450 CYP3A Inhibitors
- Cytochrome P 450 CYP3A Inhibitors
- CYP3A Inhibitors
- Inhibitors, CYP3A
- P450 CYP3A Inhibitors
- Inhibitors, P450 CYP3A
Cytochrome P-450 CYP3A7 Inhibitors- Cytochrome P-450 CYP3A7 Inhibitors
- Cytochrome P 450 CYP3A7 Inhibitors
- P450 CYP3A7 Inhibitors
- CYP3A7 Inhibitors, P450
- Inhibitors, P450 CYP3A7
- CYP3A7 Inhibitors
- Inhibitors, CYP3A7
Cytochrome P-450 CYP3A5 Inhibitors- Cytochrome P-450 CYP3A5 Inhibitors
- Cytochrome P 450 CYP3A5 Inhibitors
- P450 CYP3A5 Inhibitors
- CYP3A5 Inhibitors, P450
- CYP3A5 Inhibitors
- Inhibitors, CYP3A5
Cytochrome P-450 CYP3A4 Inhibitors- Cytochrome P-450 CYP3A4 Inhibitors
- Cytochrome P 450 CYP3A4 Inhibitors
- P450 CYP3A4 Inhibitors
- Inhibitors, P450 CYP3A4
- CYP3A4 Inhibitors
- Inhibitors, CYP3A4
|
Below are MeSH descriptors whose meaning is more general than "Cytochrome P-450 CYP3A Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Cytochrome P-450 CYP3A Inhibitors".
This graph shows the total number of publications written about "Cytochrome P-450 CYP3A Inhibitors" by people in this website by year, and whether "Cytochrome P-450 CYP3A Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2008 | 1 | 0 | 1 |
2010 | 1 | 0 | 1 |
2014 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cytochrome P-450 CYP3A Inhibitors" by people in Profiles.
-
Randomized study of danoprevir/ritonavir-based therapy for HCV genotype 1 patients with prior partial or null responses to peginterferon/ribavirin. J Hepatol. 2015 Feb; 62(2):294-302.
-
Inhibition of CYP3A by erythromycin: in vitro-in vivo correlation in rats. Drug Metab Dispos. 2010 Jan; 38(1):61-72.
-
Hydroxyitraconazole, formed during intestinal first-pass metabolism of itraconazole, controls the time course of hepatic CYP3A inhibition and the bioavailability of itraconazole in rats. Drug Metab Dispos. 2008 Jun; 36(6):1097-101.